Secretome-Based Identification and Characterization of Potential Biomarkers in Thyroid Cancer

被引：33
|
作者：
Kashat, Lawrence [1 ,2 ,3 ]
So, Anthony K. -C. [1 ,2 ]
Masui, Olena [4 ,5 ]
Wang, X. Simon [4 ,5 ]
Cao, Jun [1 ,2 ]
Meng, Xianwang [1 ,2 ]
MacMillan, Christina
Ailles, Laurie E. [6 ]
Siu, K. W. Michael [4 ,5 ]
Ralhan, Ranju [1 ,2 ,3 ,4 ,5 ,7 ,8 ]
Walfish, Paul G. [1 ,2 ,3 ,7 ,8 ]
机构：
[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada
[2] Mt Sinai Hosp, Joseph & Mildred Sonstine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[4] York Univ, Dept Chem, N York, ON M3J 1P3, Canada
[5] York Univ, Ctr Res Mass Spectrometry, N York, ON M3J 1P3, Canada
[6] Ontario Canc Inst, MaRS Ctr, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada
[7] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada
[8] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 2N2, Canada
来源：
JOURNAL OF PROTEOME RESEARCH | 2010年 / 9卷 / 11期
基金：
加拿大健康研究院;
关键词：
proteomics; one-dimensional liquid chromatography-tandem mass spectrometry; secretome; thyroid cancer; biomarkers; secretory proteins; MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; FINE-NEEDLE-ASPIRATION; CONDITIONED MEDIA; PLASMINOGEN-ACTIVATOR; PROTHYMOSIN-ALPHA; PROSTATE-CANCER; GENE-EXPRESSION; CELL-LINES; ABSOLUTE QUANTIFICATION; PROTEOMICS ANALYSIS;
D O I：
10.1021/pr100529t
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
In search of thyroid cancer biomarkers, proteins secreted by thyroid cancer cell lines, papillary-derived TPC-1 and anaplastic-derived CAL62, were analyzed using liquid chromatography-tandem mass spectrometry. Of 46 high-confidence identifications, 6 proteins were considered for verification in thyroid cancer patients' tissue and blood. The localization of two proteins, nucleolin and prothymosin-alpha. (PTMA), was confirmed in TPC-1 and CAL62 cells by confocal microscopy and immunohistochemically in xenografts of TPC-1 cells in NOD/SCID/gamma mice and human thyroid cancers (48 tissues). Increased nuclear and cytoplasmic expression of PTMA was observed in anaplastic compared to papillary and poorly differentiated carcinomas. Nuclear expression of nucleolin was observed in all subtypes of thyroid carcinomas, along with faint cytoplasmic expression in anaplastic cancers. Importantly, PTMA, nucleolin, clusterin, cysteine-rich angiogenic inducer 61, enolase 1, and biotinidase were detected in thyroid cancer patients' sera, warranting future analysis to confirm their potential as blood-based thyroid cancer markers. In conclusion, we demonstrated the potential of secretome analysis of thyroid cancer cell lines to identify novel proteins that can be independently verified in cell lines, xenografts, tumor tissues, and blood samples of thyroid cancer patients. These observations support their potential utility as minimally invasive biomarkers for thyroid carcinomas and their application in management of these diseases upon future validation.
引用
收藏
页码：5757 / 5769
页数：13
相关论文
共 50 条
  • [31] Secretome-Based Prediction of Three-Dimensional Hepatic Microtissue Physiological Relevance
    Asthana, Amish
    White, Charles McRae
    Ndyabawe, Kenneth
    Douglass, Megan
    Kisaalita, William S.
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (01) : 587 - 596
  • [32] Identification and characterization of novel candidate prostate cancer biomarkers through proteomic analysis of the secretome of three prostate cancer cell lines
    Sardana, Girish
    Marshall, John
    Diamandis, Eleftherios P.
    CANCER RESEARCH, 2006, 66 (08)
  • [33] Identification of mouse colon tumor secretome as putative biomarkers for blood-based screening of colorectal cancer
    Fijneman, Remond
    de Wit, Meike
    Pourghiasian, Maral
    Piersma, Sander
    van Diemen, Pien
    van Hinsbergh, Victor
    Smits, Ron
    Fodde, Riccardo
    Meijer, Gerrit
    Jimenez, Connie
    CELLULAR ONCOLOGY, 2008, 30 (02) : 156 - 157
  • [34] Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas
    Chaker, Seham
    Kashat, Lawrence
    Voisin, Sebastien
    Kaur, Jatinder
    Kak, Ipshita
    MacMillan, Christina
    Ozcelik, Hilmi
    Siu, K. W. Michael
    Ralhan, Ranju
    Walfish, Paul G.
    PROTEOMICS, 2013, 13 (05) : 771 - 787
  • [35] Development of secretome-based strategies to improve cell culture protocols in tissue engineering
    O. Cases-Perera
    C. Blanco-Elices
    J. Chato-Astrain
    C. Miranda-Fernández
    F. Campos
    P. V. Crespo
    I. Sánchez-Montesinos
    M. Alaminos
    M. A. Martín-Piedra
    I. Garzón
    Scientific Reports, 12 (1)
  • [36] Rhoa/ROCK, mTOR and Secretome-Based Treatments for Ischemic Stroke: New Perspectives
    Pinosanu, Elena Anca
    Pirscoveanu, Denisa
    Albu, Carmen Valeria
    Burada, Emilia
    Pirvu, Andrei
    Surugiu, Roxana
    Sandu, Raluca Elena
    Serb, Alina Florina
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (04) : 3484 - 3501
  • [37] Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach
    Xue, Hua
    Li, Bingjian
    Zhang, Jun
    Wu, Minliang
    Huang, Qiong
    Wu, Qiang
    Sheng, Hongqiang
    Wu, Dongdong
    Hu, Jianwen
    Lai, Maode
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (01) : 545 - 555
  • [38] Proteomic Characterization of Nipple Aspirate Fluid: Identification of Potential Biomarkers of Breast Cancer
    Susan M. Varnum
    Chandice C. Covington
    Ronald L. Woodbury
    Konstantinos Petritis
    Lars J. Kangas
    Mohamed S. Abdullah
    Joel G. Pounds
    Richard D. Smith
    Richard C. Zangar
    Breast Cancer Research and Treatment, 2003, 80 : 87 - 97
  • [39] Identification and characterization of active enhancers as potential biomarkers of aggressive colorectal cancer.
    Wu, R.
    Jerde, C. R.
    Diasio, R. B.
    Offer, S. M.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [40] Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer
    Varnum, SM
    Covington, CC
    Woodbury, RL
    Petritis, K
    Kangas, LJ
    Abdullah, MS
    Pounds, JG
    Smith, RD
    Zangar, RC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (01) : 87 - 97
12345